Forecast: Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases in the UK

The forecasted data indicates a gradual decline in the number of confirmed RR-/MDR-TB cases in the UK from 42 cases in 2024 to 37 cases by 2028. As of 2023, the actual number of cases stood at 43. Year-on-year variations show minor decreases of approximately 2.4% to 2.6% per year, with a compound annual growth rate (CAGR) reflecting an average year-over-year decrease across the five-year forecast period. This downward trend suggests improving control measures or innovative treatment strategies targeting drug-resistant forms of tuberculosis.

Future trends to watch for include:

  • The impact of new TB vaccination programs or drugs introduced in the pipeline.
  • Changes in healthcare policies that could affect TB detection and treatment effectiveness.
  • The influence of global TB control strategies and their adaptation in the UK.

Top Countries about Tuberculosis